Medicare Enrolled
Dr. David Prince, M.D.
Pulmonary Disease · Bryn Mawr, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Prince from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Prince?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Prince
Dr. David Prince is a pulmonary disease specialist in Bryn Mawr, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Prince performed 2,209 Medicare services across 1,430 unique beneficiaries.
Between the years covered by Open Payments, Dr. Prince received a total of $12,402 from 55 pharmaceutical and/or device companies across 477 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Prince is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 7% volume in PA
$12,402 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,209
Medicare services
Top 7% in PA for pulmonary disease
1,430
Unique beneficiaries
$105
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~110 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
556 | $175 | $364 |
| Airflow rate measurement test A test that measures the rate of airflow. This procedure assesses how quickly air moves. |
290 | $31 | $70 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
273 | $100 | $217 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
250 | $140 | $272 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
155 | $98 | $241 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
141 | $41 | $147 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
98 | $88 | $183 |
| New patient office visit, complex (60-74 min) | 93 | $167 | $308 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
59 | $142 | $319 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
51 | $8 | $32 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
44 | $48 | $90 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
43 | $37 | $72 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
38 | $32 | $93 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
31 | $28 | $55 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
25 | $10 | $25 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
20 | $15 | $29 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
15 | $96 | $270 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
15 | $94 | $160 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
12 | $73 | $399 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,402
Total received (2018-2024)
Avg $1,772/year across 7 years
Top 15% in PA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
477
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,855 (95.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$546 (4.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,242
2023
$2,423
2022
$2,096
2021
$542
2020
$399
2019
$1,532
2018
$2,167
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$692
GlaxoSmithKline, LLC.
$287
GENZYME CORPORATION
$205
Mylan Specialty L.P.
$189
Insmed, Inc.
$187
United Therapeutics Corporation
$167
Regeneron Healthcare Solutions, Inc.
$156
HARMONY BIOSCIENCES LLC
$138
Amgen Inc.
$105
Harmony Biosciences Llc
$87
Axsome Therapeutics, Inc.
$69
Mallinckrodt Hospital Products Inc.
$64
E.R. Squibb & Sons, L.L.C.
$62
Actelion Pharmaceuticals US, Inc.
$62
Philips North America LLC
$57
Takeda Pharmaceuticals U.S.A., Inc.
$54
Boehringer Ingelheim Pharmaceuticals, Inc.
$53
Electromed, Inc.
$52
Alexion Pharmaceuticals, Inc.
$50
Astellas Pharma US Inc
$49
ABBVIE INC.
$44
Bayer Healthcare Pharmaceuticals Inc.
$43
Avadel CNS Pharmaceuticals, LLC
$41
Janssen Pharmaceuticals, Inc
$37
Pulmonx Corporation
$37
ANI Pharmaceuticals, Inc.
$36
Tactile Systems Technology Inc
$35
Grifols USA, LLC
$29
Vifor Pharma, Inc.
$26
Inspire Medical Systems, Inc.
$25
La Jolla Pharmaceutical Company
$24
Paratek Pharmaceuticals, Inc.
$23
Genentech USA, Inc.
$22
Resmed Corp
$21
Merck Sharp & Dohme LLC
$14
Top 3 companies account for 36.5% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,734
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,289
GlaxoSmithKline, LLC.
$1,260
Insmed, Inc.
$892
Mylan Specialty L.P.
$746
Janssen Pharmaceuticals, Inc
$637
Genentech USA, Inc.
$569
Actelion Pharmaceuticals US, Inc.
$504
GENZYME CORPORATION
$358
Philips Electronics North America Corporation
$309
United Therapeutics Corporation
$305
Regeneron Healthcare Solutions, Inc.
$302
Amgen Inc.
$282
Harmony Biosciences LLC
$243
Grifols USA, LLC
$204
Axsome Therapeutics, Inc.
$203
Inspire Medical Systems, Inc.
$171
HARMONY BIOSCIENCES LLC
$169
ABBVIE INC.
$135
Amarin Pharma Inc.
$126
Takeda Pharmaceuticals U.S.A., Inc.
$116
Mallinckrodt LLC
$111
E.R. Squibb & Sons, L.L.C.
$111
ANI Pharmaceuticals, Inc.
$105
Alexion Pharmaceuticals, Inc.
$92
Merck Sharp & Dohme LLC
$91
Harmony Biosciences Llc
$87
Electromed, Inc.
$85
Baxter Healthcare
$78
Sunovion Pharmaceuticals Inc.
$77
Avadel CNS Pharmaceuticals, LLC
$67
Paratek Pharmaceuticals, Inc.
$66
JAZZ PHARMACEUTICALS INC.
$66
Mallinckrodt Hospital Products Inc.
$64
Bayer Healthcare Pharmaceuticals Inc.
$64
Mallinckrodt Enterprises LLC
$59
Resmed Corp
$58
Philips North America LLC
$57
Astellas Pharma US Inc
$49
PFIZER INC.
$48
Allergan Inc.
$41
Shire North American Group Inc
$39
Pulmonx Corporation
$37
ABIOMED
$35
Otsuka America Pharmaceutical, Inc.
$35
Tactile Systems Technology Inc
$35
Phadia US Inc.
$27
Vifor Pharma, Inc.
$26
La Jolla Pharmaceutical Company
$24
IDORSIA PHARMACEUTICALS US INC
$22
Vapotherm Inc
$21
Jazz Pharmaceuticals Inc.
$20
Circassia Pharmaceuticals Inc
$19
Medtronic Vascular, Inc.
$18
Teva Pharmaceuticals USA, Inc.
$13
Top 3 companies account for 34.5% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSENSE · AIRSUPRA · ANORO · ARALAST · AREXVY · AVYCAZ · Adempas · Arikayce · Astral · BEVESPI AEROSPHERE · BREO · BREZTRI · BROVANA · CHANTIX · CHARTIS CATHETER · CINQAIR · Cresemba · DUPIXENT · Dymista · ELIQUIS · Esbriet · FARXIGA · FASENRA · Flexitouch Plus · GIAPREZA · GLASSIA · Hillrom - Life 2000 Ventilation System · IMFINZI · INSPIRE · ImmunoCAP · Impella · JYNARQUE · LUMIZYME · LUMRYZ · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Perforomist · Precision Flow · Prolastin-C · Prolastin-C Liquid · QUVIVIQ · Repatha · Reveal LINQ · SAMSCA · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · Trilogy 100 · ULTOMIRIS · UPTRAVI · Ultomiris · Utibron · Vascepa · WAKIX · Wakix · Wellcentive Undiv · XARELTO · XYREM · XYWAV · Xembify · Xolair · Xyrem · YUPELRI · Yupelri · ZERBAXA · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
257
Per 100K population
44.6
County median income
$88,576
Nearest hospital
BRYN MAWR HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Prince is a clinical cardiology specialist, with above-average Medicare volume (top 7% in PA), with low-engagement industry engagement in the top 15% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Prince experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Prince performed 556 critical care, first 30-74 min services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Prince receive payments from pharmaceutical companies?
Yes. Dr. Prince received a total of $12,402 from 55 companies across 477 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Prince's costs compare to other pulmonary diseases in Bryn Mawr?
Dr. Prince's average Medicare payment per service is $105. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Prince) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Bryn Mawr
Browse pulmonary diseases in Bryn Mawr ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in PA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in PA
Which PA pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology